JPRN-jRCT2080221428未知3 期
Phase III Study of ATL-962 in Obese Patients
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Inpatient/outpatient during the run-in period: Outpatient
- •The subject can read and understand the written information/consent form and can give his/her consent to participate in this study.
排除标准
- •The subject has a serious heart disease, a cerebrovascular disease or a serious disease of the pancreas or blood.
- •The subject has been determined to be ineligible by the investigator or subinvestigator.
研究者
相似试验
未知
3 期
A phase III study of ATL-962 in subject with obesityObesityJPRN-jRCT2080220827Takeda Pharmaceutical Company Limited
已完成
1 期
Phase I Study of RTA 402 in Obese AdultsJPRN-jRCT2080224778Kyowa Kirin Co., Ltd.18
未知
2 期
A Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemiaObesityJPRN-jRCT2080222949Shionogi & Co., Ltd.
招募中
不适用
A clinical trial evaluating anti-obesity and antilipidemic effects of Schizandra chinensisEndocrine, nutritional and metabolic diseaseKCT0000649Dongguk University Ilsan Oriental Hospital30
已完成
2 期
Efficacy and Safety of ATL-962 in Obese DiabeticsNon-Insulin-Dependent Diabetes MellitusObesityNCT00156897Alizyme600